Replimune Group, Inc.

For the period ended Sep 30, 2026. Filed Oct 28, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 28, 2026

REPL$23.28+4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Amounts in thousands, except share amounts)

Common stock · Additionalpaid-incapital · Accumulateddeficit · Accumulatedothercomprehensiveincome · Totalstockholders’equity
Shares · Amount
Balances as of March 31, 2026	82,716,923	$82		$1,423,194			$(1,262,519)			$5,403			$166,160
Foreign currency translation adjustment	—	—		—			—			582			582
Unrealized loss on short-term investments	—	—		—			—			(9)			(9)
Exercise of stock options	118,075	1		1,003			—			—			1,004
Vesting of RSUs	1,144,368	1		(1)			—			—			—
Stock-based compensation expense	—	—		7,674			—			—			7,674
Net loss	—	—	—		(69,766)			—		(69,766)
Balances as of June 30, 2026	83,979,366	84		1,431,870			(1,332,285)			5,976			105,645
Issuance of prefunded warrants to purchase common stock	—	—		31,020			—			—			31,020
Issuance of common stock, net of issuance costs	9,701,490	10		109,970			—			—			109,980
Foreign currency translation adjustment	—	—		—			—			(55)			(55)
Unrealized gain on short-term investments	—	—		—			—			1			1
Exercise of stock options	652,820	1		4,762			—			—			4,763
Vesting of RSUs	471,478	—		—			—			—			—
Stock-based compensation expense	—	—		10,545			—			—			10,545
Net loss	—	—				(57,121)			—			(57,121)
Balances as of September 30, 2026	94,805,154	95		1,588,167			(1,389,406)			5,922			204,778
Balances as of March 31, 2025	77,085,024	$77		$1,358,897			$(948,579)			$5,448			$415,843
Foreign currency translation adjustment	—	—	—		—		(938)			(938)
Unrealized loss on short-term investments	—	—	—		—		(269)			(269)
Exercise of stock options	966	—		8			—		—		8
Vesting of RSUs	721,184	1		1			—		—		2
Stock-based compensation expense	—	—	8,762			—		—		8,762
Net loss	—	—	—		(86,693)			—		(86,693)
Balances as of June 30, 2025	77,807,174	78		1,367,668			(1,035,272)			4,241			336,715
Foreign currency translation adjustment	—	—		—			—			751			751
Unrealized gain on short-term investments	—	—		—			—			131			131
Exercise of pre-funded warrants	497,344	—		501			—			—			501
Vesting of RSUs	98,737	—		—			—			—			—
Stock-based compensation expense	—	—		8,338			—			—			8,338
Net loss	—	—		—			(83,100)			—			(83,100)
Balances as of September 30, 2025	78,403,255	78		1,376,507			(1,118,372)			5,123			263,336

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.